![Joseph Romanelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Romanelli
Direktor/Vorstandsmitglied bei
KIMBERLY-CLARK CORPORATION
Vermögen: 4 Mio $ am 30.06.2026
Profil
Mr. Joseph Romanelli is a President, Chief Executive Officer & Director at Tessera Therapeutics, Inc., an Independent Director at Kimberly-Clark Corp.
and a President-Human Health International at Merck & Co., Inc. He is on the Board of Directors at Tessera Therapeutics, Inc. and Kimberly-Clark Corp.
Mr. Romanelli was previously employed as a Chief Executive Officer by Jixing Pharmaceutical Technology (Shanghai) Co., Ltd., a Head-Investor Relations by Merck & Co., Inc., and a Head-Investor Relations by Schering-Plough Corp.
USA. He received his undergraduate degree from the University of Delaware and an MBA from Gabelli School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.01.2026 | 28’739 ( 0% ) | 4 Mio $ | 30.06.2026 | |
| 02.01.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Joseph Romanelli
| Unternehmen | Position | Beginn |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01.08.2022 |
| KIMBERLY-CLARK CORPORATION | Direktor/Vorstandsmitglied | 13.11.2024 |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Vorstandsvorsitzender | 23.07.2026 |
Ehemalige bekannte Positionen von Joseph Romanelli
| Unternehmen | Position | Ende |
|---|---|---|
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Vorstandsvorsitzender | 01.07.2022 |
| MERCK & CO., INC. | Investor Relations Kontakt | 01.07.2015 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Public Communications Contact | 04.11.2009 |
Ausbildung von Joseph Romanelli
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Kimberly-Clark Corp.
 Kimberly-Clark Corp. Household/Personal CareConsumer Non-Durables Manufactures paper based products and provides cleaning solutions | Consumer Non-Durables |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gabelli School of Business
 Gabelli School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Health Technology |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Health Technology |
